Disclosed security · Transaction Sep 26, 2017 · Filed Oct 3, 2017 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · OPK
-0.59% · -$0.0100 · Vol Not reported
Pre-market · updated 05:14:06 ET
OPKO Health Inc
Health Care
$1.68
Follow $OPK
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $OPK by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredMon Sep 21 · last completed session · Pre-market · regular session opens 9:30 ET · OPK
MethodologyOPK
OPKO Health Inc
Mon Sep 21 · last completed session · Pre-market · regular session opens 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
74/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Mon Sep 21 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is OPK moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About OPKO Health Inc
PHARMACEUTICAL PREPARATIONSListed since
1995
Employees
2K
Country
US
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$1.69
Last session
Day high
$1.69
Last session
Day low
$1.69
Last session
Previous close
$1.69
52W high
$1.69
-0.59% from high
52W low
$1.10
98% of range
Market cap
$1.3B
EPS
$-0.2400
Beta
0.87
Shares out
746.3M
Avg volume
2.8M
VWAP
$1.69
Last session
Price history computed in-house
1W
+7.01%
1M
+13.51%
3M
+12.75%
1Y
+16.67%
YTD
+33.33%
SMA 50 $1.42 · above
SMA 200 $1.31 · above
52W position 98%
OPK overview
Related filings and maps
Public disclosures
Congress activity in OPK
Official filing ↗
Opko Health, Inc. · Transaction Sep 26, 2017 · Filed Oct 3, 2017 · $1,001 to $15,000
Federal contracts
OPK contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for OPK in this window.
Lobbying spend
OPK lobbying filings, year to date.
Registered lobbying filings matched to OPKO Health Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for OPK in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for OPK.
Options
Sovereign unlock shows live options positioning for OPK.